Attached files
| file | filename |
|---|---|
| 10-K - Jiangbo Pharmaceuticals, Inc. | v197623_10k.htm |
| EX-31.2 - Jiangbo Pharmaceuticals, Inc. | v197623_ex31-2.htm |
| EX-31.1 - Jiangbo Pharmaceuticals, Inc. | v197623_ex31-1.htm |
| EX-99.8 - Jiangbo Pharmaceuticals, Inc. | v197623_ex99-8.htm |
| EX-32.1 - Jiangbo Pharmaceuticals, Inc. | v197623_ex32-1.htm |
EXHIBIT
32.2
CERTIFICATION
OF PRINCIPAL FINANCIAL OFFICER
PURSUANT
TO 18 USC § 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY
ACT OF 2002
In
connection with the annual report of Jiangbo Pharmaceuticals, Inc. (“the
Company”) on Form 10-K for the period ended June 30, 2010 as filed with the
Securities and Exchange Commission on the date hereof (“the Report”), I, Elsa
Sung, Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my
knowledge:
|
|
(a)
|
The annual report on Form 10-K
for the year ended June 30, 2010 of the Company fully complies with the
requirements of section 13(a) or 15(d) of the Securities Exchange Act of
1934; and
|
|
|
(b)
|
Information contained in the Form
10-K fairly presents, in all material respects, the financial condition
and results of operations of the
Company.
|
Dated:
September 28, 2010
|
/s/ Elsa Sung
|
|
|
Elsa
Sung
|
|
|
Chief
Financial Officer
|